Search results for "Analgesics"

showing 10 items of 260 documents

Arginine-rich peptides are blockers of VR-1 channels with analgesic activity

2000

Vanilloid receptors (VRs) play a fundamental role in the transduction of peripheral tissue injury and/or inflammation responses. Molecules that antagonize VR channel activity may act as selective and potent analgesics. We report that synthetic arginine-rich hexapeptides block heterologously expressed VR-1 channels with submicromolar efficacy in a weak voltage-dependent manner, consistent with a binding site located near/at the entryway of the aqueous pore. Dynorphins, natural arginine-rich peptides, also blocked VR-1 activity with micromolar affinity. Notably, synthetic and natural arginine-rich peptides attenuated the ocular irritation produced by topical capsaicin application onto the eye…

ArginineReceptors DrugBiophysicsTRPV Cation ChannelsPainDynorphinPharmacologyArginineEyeDynorphinsBiochemistryInhibitory Concentration 50MiceXenopus laevisDynorphinchemistry.chemical_compoundStructural BiologyNon-competitive antagonistGeneticsAnimalsChannel blockerAmino Acid SequenceBinding siteReceptorMolecular BiologyNon-competitive antagonistAnalgesicsChemistryElectric ConductivityNociceptorCell BiologyCapsaicinIonic poreOocytesNociceptorCapsaicinPeptidesFEBS Letters
researchProduct

Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression

2009

Abstract In a previous study, we reported a new γ-hydroxybutenolide derivative, 4-benzo[ b ]thiophen-2-yl-3-bromo-5-hydroxy-5 H -furan-2-one (BTH), as inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1) expression in lypopolysaccharide (LPS) stimulated RAW 264.7 and TPH-1 cells, without affecting cyclooxygenase-2 (COX-2). In this study, we evaluated the in vivo effect of BTH on some acute and chronic inflammatory animal models in relation to its inhibitory profile on mPGES-1 expression. In the zymosan-induced mouse air pouch model, BTH produced a dose-dependent inhibition of prostaglandin E 2 (PGE 2 ) production and mPGES-1 protein expression in pouch exudates without any effect on…

Blood PlateletsMaleNeutrophilsmedicine.drug_classmedicine.medical_treatmentAnti-Inflammatory AgentsProstaglandinInflammationThiophenesAcetatesPharmacologyProstaglandin E synthaseLeukotriene B4Gene Expression Regulation EnzymologicAnti-inflammatoryMicechemistry.chemical_compound4-ButyrolactoneIn vivomedicineAnimalsHumansProstaglandin-E SynthasesInflammationPharmacologyAnalgesicsBehavior AnimalbiologyArthritis ExperimentalIntramolecular OxidoreductasesThromboxane B2BiochemistrychemistryHyperalgesiaChronic DiseaseHyperalgesiabiology.proteinCattlelipids (amino acids peptides and proteins)Arachidonic acidmedicine.symptomProstaglandin E
researchProduct

Agkistrodon ameliorates pain response and prevents cartilage degradation in monosodium iodoacetate-induced osteoarthritic rats by inhibiting chondroc…

2019

Abstract Ethnopharmacological relevance Osteoarthritis (OA), characterized by joint pain and cartilage degradation, is the most common form of joint disease worldwide but with no satisfactory therapy available. The ethanol extract of Agkistrodon acutus (EAA) has been widely used as a traditional Chinese medicine (TCM) for the treatment of arthralgia and inflammatory diseases, but there is no report regarding its efficacy on OA to date. Here, we determined the effects of EAA on the pain behavior and cartilage degradation in vivo and clarified its target genes and proteins associated with chondrocyte hypertrophy and apoptosis in vitro. Materials and methods In vivo OA model was established by…

Cartilage ArticularMalePainChondrocyte hypertrophyApoptosisOsteoarthritisPharmacologyComplex MixturesChondrocyteRats Sprague-Dawley03 medical and health sciencesAnimal data0302 clinical medicineChondrocytesIn vivoDrug DiscoveryOsteoarthritismedicineAnimalsViability assay030304 developmental biologyPharmacology0303 health sciencesAnalgesicsChemistryCartilageHypertrophymedicine.diseaseIodoacetic Acidmedicine.anatomical_structureApoptosis030220 oncology & carcinogenesisAgkistrodonJournal of ethnopharmacology
researchProduct

Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor

2007

Abstract Recently, we reported the dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) activity by some phenylsulphonyl urenyl chalcone derivatives. 2,4-dichloro-4′ N [ N ′(4″methylphenylsulphonyl)urenyl] chalcone (Me-UCH9), was selected in the present study to determine its potential anti-inflammatory and analgesic effect after oral administration in several animal models related to the activation of COX-2 and 5-LO pathways. In the zymosan stimulated mouse air pouch model, Me-UCH9, reduced in a dose-dependent manner leukotriene B 4 (LTB 4 ) levels in pouch exudates obtained at 4 h, as well as prostaglandin E 2 (PGE 2 ) generated through COX-2 activation at 24 h. Tumor nec…

Chalconemedicine.drug_classStereochemistrymedicine.medical_treatmentAnalgesicAnti-Inflammatory AgentsArthritisPharmacologyCarrageenanGeneral Biochemistry Genetics and Molecular BiologyAnti-inflammatoryMicechemistry.chemical_compoundChalconesOral administrationmedicineAnimalsEdemaHumansCyclooxygenase InhibitorsLipoxygenase InhibitorsEnzyme InhibitorsRats WistarGeneral Pharmacology Toxicology and PharmaceuticsAnalgesicsDose-Response Relationship Drugbiologybusiness.industryZymosanGeneral Medicinemedicine.diseaseArthritis ExperimentalRatschemistryCyclooxygenase 2biology.proteinFemaleCyclooxygenasebusinessProstaglandin ELife Sciences
researchProduct

Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem …

2015

Abstract A liquid chromatography–tandem mass spectrometry method using electrospray ionization in positive ionization mode was developed for the simultaneous detection of multiple opioid-type drugs in plasma. The presented assay allows the quantitative determination of alfentanil, buprenorphine, codeine, desomorphine, dextromethorphan, dextrorphan, dihydrocodeine, dihydromorphine, ethylmorphine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, naloxone, naltrexone, oxycodone, oxymorphone, pentazocine, pethidine, pholcodine, piritramide, remifentanil, sufentanil, and tramadol as well as the metabolites 6-monoacetylmorphine, bisnortilidine, morphine-3-glucuronide, morphine-6-glucuro…

ChromatographyChemistryClinical BiochemistryCodeineReproducibility of ResultsCell BiologyGeneral MedicineEthylmorphineBiochemistryDihydrocodeineAnalytical ChemistryTriple quadrupole mass spectrometerBody FluidsAnalgesics Opioidchemistry.chemical_compoundLiquid chromatography–mass spectrometryLimit of DetectionTandem Mass SpectrometryIntensive caremedicineMorphineHumansNorbuprenorphinemedicine.drugChromatography LiquidJournal of chromatography. B, Analytical technologies in the biomedical and life sciences
researchProduct

Biosensor-based kinetic and thermodynamic characterization of opioids interaction with human μ-opioid receptor.

2019

Development of opioid analgesics with minimal side effects requires substantial knowledge on structure-kinetic and -thermodynamic relationship of opioid-receptor interactions. Here, combined kinetics and thermodynamics of opioid agonist binding to human μ-opioid receptor (h-μOR) was investigated using real-time label-free surface plasmon resonance (SPR)-based method. The N-terminal end truncated and C-terminal 6His-tagged h-μOR was constructed and expressed in E. coli. Receptor was purified, detergent-solubilized and characterized by circular dichroism. The uniform immobilization of h-μOR on Ni-NTA chips was achieved using hybrid capture-coupling approach followed by reconstitution in lipid…

Circular dichroismThermodynamic equilibriummedicine.drug_classEnthalpyReceptors Opioid muPharmaceutical Science02 engineering and technology(+)-NaloxoneBiosensing Techniques030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineOpioid receptormedicineEscherichia coliHumansSurface plasmon resonanceLipid bilayerMorphineChemistryNaloxone021001 nanoscience & nanotechnologyAnalgesics OpioidKineticsOpioidBiophysicsThermodynamics0210 nano-technologymedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Adolescents' medicine use for headache: secular trends in 20 countries from 1986 to 2010

2015

BACKGROUND: This study reports secular trends in medicine use for headache among adolescents in 20 countries from 1986 to 2010.METHODS: The international Health Behaviour in School-aged Children (HBSC) survey includes self-reported data about medicine use for headaches among nationally representative samples of 11-, 13- and 15-year-olds. We included 20 countries with data from at least three data collection waves, with a total of 380 129 participants.RESULTS: The prevalence of medicine use for headaches varied from 16.5% among Hungarian boys in 1994 to 62.9% among girls in Wales in 1998. The prevalence was higher among girls than boys in every country and data collection year. The prevalenc…

CzechMalemedicine.medical_specialtyPediatricsAdolescentmedication useperceptionsSex FactorschildrenmedicineHumansadolescentsSelf reportMedicine useChildtimeAnalgesicsData collectionmedicine usebusiness.industryPublic healthPublic Health Environmental and Occupational HealthHeadacheInternational healthta3142ArticlesHealth Surveyslanguage.human_languageSecular variationEuropeAdolescent BehaviorFamily medicineNorth AmericalanguageFemaleHeadachesmedicine.symptombusiness
researchProduct

Eficacia analgésica del diclofenaco sódico vs. ibuprofeno después de la extracción quirúrgica de un tercer molar inferior incluido

2004

-Objetivo: En este estudio evaluamos la eficacia analgésica del diclofenaco sódico en comparación con el ibuprofeno, después de la extracción quirúrgica de un tercer molar inferior incluido. -Diseño de estudio: Los pacientes que participaron en el estudio fueron distribuidos de forma aleatoria en dos grupos. Uno fue el grupo ibuprofeno y el otro el grupo diclofenaco. La intervención practicada fue la extracción quirúrgica de un tercer molar inferior cuya dificultad fue determinada en función del grado de inclusión en todos los pacientes. Las variables registradas fueron la intensidad del dolor y la necesidad de medicación de rescate durante un periodo de una semana. Los registros se realiza…

Diclofenaco sódicoAnalgesicsOdontologíaDent molaranalgésico-antiinflamatorio:CIENCIAS MÉDICAS [UNESCO]MolarCiencias de la saludAnalgèsicsUNESCO::CIENCIAS MÉDICASTeeth extractionextracción quirúrgica de terceros molaresExtracció dentalibuprofeno
researchProduct

Treating breakthrough pain in oncology

2018

Breakthrough cancer pain (BTcP) is an episode of severe intensity in patients receiving an adequate treatment with opioids able to provide at least mild analgesia. BTcP is a heterogeneous condition as episodes vary between individuals. The aim of this article is to review the pharmacologic options for the management of BTcP. Areas covered: Recent reviews revealed that transmucosal preparations of fentanyl provided superior and more rapid pain relief as compared to placebo and oral morphine within the first 30 min after dosing. Few comparison studies among fentanyl products have been performed. Although dose titration has been recommended for years, a meaningful dosing, according to the leve…

Dose-Response Relationship DrugMorphinebusiness.industryBreakthrough PainBreakthrough PainAdministration BuccalAdministration OralCancer PainAnalgesics OpioidFentanyl03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisAnesthesiaHumansMedicinePharmacology (medical)In patientbusinessCancer pain030217 neurology & neurosurgeryExpert Review of Anticancer Therapy
researchProduct

Why are our patients still suffering pain?

2007

Legal barriers, restricted resources, lack of physician training, and physician and patient worries about potential opioid addiction can be barriers to effective and rational pain management in patients with cancer pain. Sebastiano Mercadante discusses these issues, as well as suggesting interventions for improving care.

Drug UtilizationNarcoticsmedicine.medical_specialtyCulturePsychological interventionMEDLINEPainNeoplasmsPhysiciansmedicineHumansPain ManagementIn patientIntensive care medicineOpioid addictionPain MeasurementAnalgesicsEducation Medicalbusiness.industryfood and beveragesGeneral MedicinePain managementDrug UtilizationOncologyAttitudeCaregiversDrug and Narcotic ControlbusinessCancer painNature clinical practice. Oncology
researchProduct